These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2948387)

  • 1. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
    Jung-Hoffmann C; Kuhl H
    Am J Obstet Gynecol; 1987 Jan; 156(1):199-203. PubMed ID: 2948387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
    März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
    Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestagen-dependent effect on some plasma proteins during oral contraception.
    Liukko P; Erkkola R; Bergink EW
    Gynecol Obstet Invest; 1988; 25(2):118-22. PubMed ID: 2967233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen.
    Sobbrio GA; Granata A; Granese D; D'Arrigo F; Panacea A; Nicita R; Pullè C; Trimarchi F
    Clin Exp Obstet Gynecol; 1991; 18(1):43-5. PubMed ID: 1829029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone.
    van der Vange N; Blankenstein MA; Kloosterboer HJ; Haspels AA; Thijssen JH
    Contraception; 1990 Apr; 41(4):345-52. PubMed ID: 2139843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH; Poulsen HK; Teisner B; Thorsen P; Hau J; Westergaard JG
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives.
    Hümpel M; Täuber U; Kuhnz W; Pfeffer M; Brill K; Heithecker R; Louton T; Steinberg B; Seifert W; Schütt B
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):329-33. PubMed ID: 2142574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
    Breitkopf DM; Rosen MP; Young SL; Nagamani M
    Contraception; 2003 May; 67(5):349-53. PubMed ID: 12742556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
    Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    Coenen CM; Thomas CM; Borm GF; Rolland R
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
    Bergink EW; Holma P; Pyörälä T
    Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
    Kloosterboer HJ; Rekers H
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):370-3. PubMed ID: 2142577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
    Kuhnz W; Sostarek D; Gansau C; Louton T; Mahler M
    Am J Obstet Gynecol; 1991 Sep; 165(3):596-602. PubMed ID: 1892184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
    Nilsson B; von Schoultz B
    Gynecol Obstet Invest; 1989; 27(3):151-4. PubMed ID: 2525511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2.
    Kuusi T; Nikkilä EA; Tikkanen MJ; Sipinen S
    Atherosclerosis; 1985 Mar; 54(3):251-62. PubMed ID: 3158321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives containing desogestrel or levonorgestrel.
    Swinkels LM; Meulenberg PM; Ross HA; Benraad TJ
    Ann Clin Biochem; 1988 Jul; 25 ( Pt 4)():354-9. PubMed ID: 2975155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.